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ABSTRAK 
A M  H PENELZTIAN HER4 TI TZS hll NAMRU-2 
Titik berat penelitian hepatitis di N M U - 2  pada saat ini adalah: I )  penelitian binatang untuk 
mengetahui populasi reservoar HEV; 2) penggunaan model hewan untuk lehih diketahuinya transmisi 
HEV pada populasi reservoar yang dicurigai; 3) diketahuinya akurasi alat diagnostik yang 
digunakan (untuk semua marker); 4) diketahzrinya lama pengeluaran virus hepatitis E pada kotoran 
manusia yang menderita hepatitis akur maupun dari model hewan; 5) djketahuinya insidens hepatitis 
E akut melalui pencariarr kasus dengan menggunnkan metode penelitian lapangan di maqarakat; dun 
6) serokonversi infeksi hepatitis E pada anak-anak. 
Hubungan erat dengan berbagai universitas dun instansi pemerinto;? yqng terkait dengan 
penanganan kasus-kasus hepatitis, telah dun masih menjadi bagian penting bagi suksesnya penelitian 
hepatitis di N M U - 2 .  Hasil yang dicapai berdasarkan program penelitian di atas antara lain: I )  
seminar hepatitis E di Kalimantan Barat; 2) tersedzanya kemampuan diagnostik pada laboratorium 
setempat; 3) pembinaan peneliti di Indonesia dun Asia Tenggura dalam ha1 epidemiologi; serta 4) alih 
tcknologi dalam pelaksanaan penelitian yagg dapat melibatkan minat para peneliti pada penyakit 
hepatitis di Indonesia. 
HEPATITIS 
Viral hepatitis is one of the principal 
causes of acute morbidity and mortality 
worldwide. The important role of viral hepatitis 
in producing chronic and progressive liver 
diseases has been well documented. The risks 
factors associated with the spread of hepatitis 
are generally virus specific. Water-borne and 
person-to-person contact, and needle sharing 
and exchange of bodily fluids via sexual 
exposure, are related to the transmission of 
hepatitis A (HAW and hepatitis B viruses 
(Hl3V) respectively. 
Previously, serological capability was 
limited to HAV and HBV detection. However, 
recent advances in laboratory diagnostic 
technologies have provided for the differen- 
tiation non-A, non-R hepatitis illto separate 
viruses: C, D, E, and FIG. The U.S. Naval 
Medical Research Unit No.2 (NAMRU-2), in 
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partnership with NIHRD, and Prof. H.A. 
Sulaiman (Medical Faculty, University of 
Indonesia, Cipto Mangunkusumo Hospital), has 
conducted a hepatitis research program to better 
outline all epidemiological profile of the newly 
recognized hepatitis viruses. 
METHODS 
Methods in studies supparted by 
NAMRU-2 involve both community and 
hospital based design concepts. Community- 
based investigations include cross-sectional 
surveys, case follow-up (after initial outbreak) 
surveys, disease outbreak investigations, and 
longitudinal studies of both active and passive 
case detection. Hospital-based studies are 
uniform in targeting: 1) high risk groups, i.e., 
recipients of multiple blood transfusions, and 2) 
patients with acute hepatitis disease. Hepatitis 
cases in hospital based studies are generally 
agelsex matched for comparative purposes. 
HEPATITIS C VIRUS (HCV) has been 
documented as an important cause of both acute 
hepatitis and hepatic cirrhosiss. A significant 
risk has also been associated between HCV 
infection and hepatocellular carcinoma9. Blood 
2nd blood product mediated transmission has 
been implicated in the spread of HCV'. In 
Egypt, HCV infection was detected among 55% 
of pediatric cases with histories of multiple 
blood transfusions, compared with less than 1% 
in healthy, non-transfused controls ". 
Overall prevalence of HCV among 7572 
healthy Indonesian blood donors from (21 out of 
27 Indonesian provinces) was 2.1% ". Figure 1 
shows the geographical mapping of prevalence 
of antibody against HCV (anti-HCV) from 
throughout the archipelago. Java and Bali had 
the highest proportion of anti-HCV positives 
with 2.5%, followed by Sulawesi, Sumatra, 
Kalimantan, and Eastern Indonesia: 1.8%, 
1.7%, 1.5%, and 1.09'0, respectively. There 
were no si@cant differences in anti-HCV 
prevalence between male and female 
populations. The proportion of anti-HCV 
positive reactives increased significantly 
@<0.001) with age, ranging from 1.0 to 10.3 
percent. Also, the mean age of anti-HCV 
positives (42.0) was significantly higher 
(p<0.001) than for negatives (32.7), but this 
may simply be the result of increasing risk of 
surgery and transfusion that occurs as 
Individuals grow..older. Risk factors found in 
association with the presence of anti-HCV were 
history of surgery, acupuncture, intravenous 
medication @<0.001), and blood transfusion(s) 
@<0.0001). 
A study of Indonesian children with 
hematological conditions from the Pediatrics 
Departments, Dr. Cipto Mangunkusumo, 
University of Indonesia Hospital, was carried 
out to determine if transmission of HCV was 
related to receipt of blood and blood products 
and the contribution it makes to the spread of 
HCV in Indonesia. Seventy-six blood product 
recipients and 74 agehex matched controls (85 
males and 65 females) with no hstory of 
clinical jaundice or transfusions were tested for 
anti-HCV. The mean age of cases and controls 
was 8.1 years, ranging from less than 1 to 13 
years. Mothers (75) of hematological case 
subjects were also evaluated for anti-HCV. 
Overall, anti-HCV among all 225 study 
participants was 15.6% using anti-HCV ELISA 
testing. The percent of anti-HCV positives 
among cases (39%) was significantly higher 
(p<0.0001) than for controls (2.7%) or 
case-mothers (4%). Anti-HCV prevalence was 
significantly lower (p=0.05) among males 
(36%) than for females (44%). The mean age 
of anti-HCV positive blood product recipients 
(9.3 years) was significantly higher (p<0.05) 
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than those of anti-HCV negatives blood product 
recipients (7.7 years). There was no increase in 
case risk with the number of blood only and 
blood product transfusions (p>0.05). However, 
the mean number of blood only transfusions 
among anti-HCV positive Blood Protect 
Recipient (10.8) was significantly higher 
(p<0.05) than for anti-HCV negative Blood 
Protect Recipient (8.8). Circumcision was 
shown to be strongly associated with anti-HCV 
case reactivity for both males (p=0.05) and 
females (p<O .0 5). 
An investigation as to the risk of HCV 
among renaldialysis patients was conducted in 
collaboration with Gatot Subroto Army 
Hospital. Renal-dialysis cases (1 50) were 
agelsex matched with hospital controls (150). 
Sixty-nine percent of dialysis patients were 
anti-HCV positive. Anti-HCV reactivity was 
negligible (<2%) among controls. 
The costs of testing blood and related 
products for anti-HCV must be weighed against 
those of acute and chronic disease in 
formulating screening policies. However, high 
anti-HCV prevalence among healthy blood 
donors, particularly in the population aged >40 
years (5.6%), warrants concern. Additionally, 
blood-related exposure via multiple transfusions 
and dialysis clearly constitutes significant risk 
relative to HCV infection. Also, the large 
percentage of anti-HCV positive non- 
hematological-related pediatric controls (2.7%) 
suggests that over 100,000 children (I 12 
years) from the Jakarta area may have been 
infected with hepatitis C virus (extrapolated 
from cencus data). Efforts to insure safe 
(avoidance of multiple needle sharing) along 
with effective immunization should be 
emphasized, 
HEPATITIS E VIRUS (HEV) infection has 
been well documented throughout Asia. First 
identified during the 1956 outbreak in India 
involving at least 29,000 cases, enterically 
transmitted HEV has since been detected in 
epidemic form from the neighboring countries 
of Pakistan, Nepal and Myanmar'.". Most cases 
of enterically transmitted non-A, non-B 
hepatitis (ET-NANBH), acquired in both 
epidemic and endemic settings, can be 
attributed to HEV infections5. Like hepatitis A 
virus (HAV), water-borne spread of HEV is 
associated with fecal contamination of water 
supplies. However, in contrast with HAV, 
epidemic HEV is generally characterized by: 1) 
.i longer incubation period; 2) higher 
case-fatality rates, particularly among pregnant 
women (10-24%); and 3) poor protective value 
of gamma gl~bulin~. '~.  
In Indonesia, HEV was the causative agent 
in an outbreak reported from West Kalimantan 
during October/November 19874.i6. The HEV 
virus was implicated as responsible in 
approximately 2500 acute hepatitis cases on the 
basis of evaluation of 28 (out of 34) acutely 
jaundiced patients who tested negative for both 
IgM anti-HAV and IgG anti-HBc, but positive 
for anti-HEV in acute serai4. A second outbreak 
(following that reported in 1987) of HEV 
transmission was recognized from West 
Kalimantan in September, 1991, among a 
different, though contiguous, group of isolated 
communities further downstream along a 20 
kilometer stretch of the same river system. An 
attack rate of 9% was estimated among a 
population of approximately 20,000. Overall, 
the case-fatality rate was 9.511000 persons with 
higher rate among pregnant women, 14% (3 out 
of 22) (BERITA EPIDEMIOLOGI, 1991). 
Laboratory testing was based on the serological 
presence of IgG anti-HEV in the absence of IgM 
anti-HAV and IgM anti-HBciZ. 
A two-year follow-up investigation of the 
1991 hepatitis E virus (HEV outbreak in West 
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Kalimantan, Indonesia, was camed out to 
describe the epidemiology of HEV transmission 
and documented persistence of IgG antibody 
response6. This study was performed in 
collaboration with Dinas Kesehatan Kabupaten 
Sintang, West Kalimantan; Kantor Wilayah 
Departemen Kesehatan, Propinsi Kalimantan 
Barat, Pontianak, West Kalimantan; and 
NIHRD, Jakarta. Cases (60) identified as IgG 
anti-HEV positives during the actual outbreak 
in 1991 were matched with controls (67) and 
surveyed along with their respectively family 
members (3 18). Overall, the prevalence of IgG 
anti-HEV among the 445 study subjects 
representing 127 study households was 59%. 
There was no significant differences in 
anti-HEV prevalence between cases (72%) and 
controls (61%). Loss of detectable IgG 
anti-HEV after 2 years was demonstrated in 
28% of case subjects who were originally 
screened as reactive for anti-HEV during the 
1991 outbreak. Cross-sectional prevalence was 
found to increase with age (p=0.01). When 
communities were grouped into areas of low 
(<40%), medium (40-59%) and high (2 60%) 
anti-HEV prevalence, use of river water for 1) 
drinking and cooking; 2) bathing; and 3) 
human waste dsposal were associated with high 
prevalence communities (p<0.001, for all 
comparisons). Conversely, boiling of water for 
drinking purposes was negatively associated 
@<0.05) with increased prevalence. There is 
evidence to suggest that lower dilution of the 
virus with river water further upstream probably 
led into a more concentrated exposure, and 
consequently, high attack rates (infection 
accompanied by disease); attack rates decreased 
in communities downstream, although 
community prevalence 2 years later did not. 
Finally, subnormal rainfail during the month 
August leading up to the 1991 outbreak (19 
centimeters compared to 209 centimeters for 
monthly mean (August) for the years 
1985-1993) may have contributed to favorable 
epidemic conditions. 
A cross-sectional survey of communities 
affected during the 1987 outbreak and a control 
area further downstream was conducted in 
1994, again, in cooperation with provincial and 
local health authorities from Pontianak and 
Sintang, West Kalimantan. Sera collected from 
885 persons were assayed (EIA) for IgG 
anti-HEV and IgG anti-HAV. Overall IgG 
anti-HEV prevalence was 40% (both in 
outbreak affected and control areas), whereas 
90% of prior study subjects had IgM anti-HAV 
markers. Prevalence of IgG anti-HEV in the 
study areas (50%) was significantly higher than 
in the control areas (23%, p<0.0001); 
community prevalence declined from a high of 
55% upriver to a low of 15% downriver (control 
area). Prevalence in the affected area increased 
by age @<0.01); no significant rise in age 
specific prevalence was noted in the control area 
(Figure 2). Hepatitis E virus prevalence in the 
population aged 2 7  years (53%) from the 
outbreak area (alive during the actual outbreak) 
was significantly higher @<0.01) than among 
children aged <7 years (born after the outbreak) 
( 'YO) .  In contrast, there was no sigIuficant 
difference in IgG anti-HEV prevalence between 
the 2 7  (23%) and <7 (20%) age groups from 
the control area. This study indicates 
continuing (sporadic) infections given IgG 
anti-HEV prevalence i ~ i  children <7 years from 
the outbreak area (15%). 
A summation of data from Indonesia, and 
more recently from NAMRU-2 supported 
hepatitis investigations in Vietnam (where the 
first outbreak HEV in Indo-China was 
documented), indicates that universal usage of 
non-treated river water for drinking purposes 
(in the absence of boiling) in a rural 
environment, favors epidemic HEV 
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Figure 2. Anti-HE\' Prevarrmce, Sintang, West Kalimantan, 1993-1994. 
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transmission7. Moreover, HEV should be 
weighed against HAV as the major cause of 
water-borne, enteric outbreaks, particularly in 
Southeast Asia, were over 95% of most rural 
populations are exposed to HAV as young 
childrenI5. 
HEPATITIS G VIRUS (HGV) has recently 
been identified in hepatitis patients from the 
Americas' and Africaz. NAMRU-2, working 
closely with diagnostic manufacturers, is 
planning to determine the presence of HGV in 
different populations. Preliminary (yet to be 
confirmed) data suggest tie first detection of 
this newly recognized virus in Indonesia 
(COR WIN et al., 1995, unpublished data). 
CONCLUSION 
I 
Emphasis of hepatitis research at 
1 NAMRU-2 now includes : 1) animal surveys to 
iden* HEV reservoir populations; 2) animal 
modeling to better understand HEV 
transmission in suspected reservoir popula- 
tions; 3) reliability assessment of diagnostic 
tests (all markers); 4) persistence of viral 
(HEV) shedding from human patients with 
acute hepatitis and animal models; 5) incidence 
of acute HEV cases through community-based 
case detection; and 6) seroconversions of HEV 
infection in children. Strong relationships have 
been and remain essential to NAMRU-2's 
successful hepatitis research. This program has 
supported hepatitis seminars in West 
Kalimantan and provided diagnostic laboratory 
and epidemiological training to collaborating 
investigators throughout the archipelago, as 
well as Southeast Asia. The transfer of research 
capabilities allows NAMRU-2 to expand its 
support of independent projects involving 
shared hepatitis research interests with 
would-be Indonesian investigators. 
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